Rick Hodder

2.2k total citations
29 papers, 1.6k citations indexed

About

Rick Hodder is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Rick Hodder has authored 29 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Pulmonary and Respiratory Medicine, 15 papers in Physiology and 3 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Rick Hodder's work include Chronic Obstructive Pulmonary Disease (COPD) Research (16 papers), Asthma and respiratory diseases (12 papers) and Respiratory and Cough-Related Research (8 papers). Rick Hodder is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (16 papers), Asthma and respiratory diseases (12 papers) and Respiratory and Cough-Related Research (8 papers). Rick Hodder collaborates with scholars based in Canada, United Kingdom and United States. Rick Hodder's co-authors include Jean Bourbeau, Paul Hernandez, Meyer Balter, Roger Goldstein, André Gervais, Denis E. O’Donnell, Jeremy Road, Shawn D. Aaron, Darcy D. Marciniuk and Gordon Ford and has published in prestigious journals such as Journal of Allergy and Clinical Immunology, Thorax and Drugs.

In The Last Decade

Rick Hodder

29 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rick Hodder Canada 19 1.2k 681 205 140 110 29 1.6k
Byron Thomashow United States 26 2.0k 1.7× 593 0.9× 104 0.5× 349 2.5× 142 1.3× 83 2.5k
Md Mahmudur Rahman Siddiqui Bangladesh 5 1.3k 1.1× 545 0.8× 98 0.5× 168 1.2× 112 1.0× 27 1.5k
Md Mostafizur Rahman Bangladesh 4 1.3k 1.1× 544 0.8× 92 0.4× 163 1.2× 110 1.0× 13 1.5k
Pere Almagro Spain 25 2.0k 1.7× 939 1.4× 144 0.7× 291 2.1× 127 1.2× 61 2.3k
Paul Walker United Kingdom 18 1.4k 1.2× 529 0.8× 109 0.5× 237 1.7× 160 1.5× 51 1.7k
Pascual Piñera Spain 18 871 0.7× 486 0.7× 70 0.3× 293 2.1× 62 0.6× 92 1.4k
Stephen Chua United Kingdom 6 1.1k 0.9× 360 0.5× 103 0.5× 174 1.2× 147 1.3× 9 1.4k
Pedro Almagro Spain 12 1.2k 1.0× 230 0.3× 96 0.5× 292 2.1× 125 1.1× 20 1.3k
Anacleto D. Gano United States 8 980 0.8× 343 0.5× 173 0.8× 345 2.5× 327 3.0× 9 2.1k
Jesús Molina Spain 27 2.3k 1.9× 1.3k 2.0× 110 0.5× 257 1.8× 226 2.1× 82 2.6k

Countries citing papers authored by Rick Hodder

Since Specialization
Citations

This map shows the geographic impact of Rick Hodder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rick Hodder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rick Hodder more than expected).

Fields of papers citing papers by Rick Hodder

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rick Hodder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rick Hodder. The network helps show where Rick Hodder may publish in the future.

Co-authorship network of co-authors of Rick Hodder

This figure shows the co-authorship network connecting the top 25 collaborators of Rick Hodder. A scholar is included among the top collaborators of Rick Hodder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rick Hodder. Rick Hodder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fink, James B., Gene Colice, & Rick Hodder. (2013). Inhaler Devices for Patients with COPD. COPD Journal of Chronic Obstructive Pulmonary Disease. 10(4). 523–535. 27 indexed citations
2.
Hodder, Rick, et al.. (2011). Lack of paradoxical bronchoconstriction after administration of tiotropium via Respimat® Soft Mist™ Inhaler in COPD. International Journal of COPD. 6. 245–245. 12 indexed citations
3.
Hodder, Rick, et al.. (2010). The MRC dyspnoea scale by telephone interview to monitor health status in elderly COPD patients. Respiratory Medicine. 104(7). 1027–1034. 20 indexed citations
4.
Hill, Kylie, Roger Goldstein, G. H. Guyatt, et al.. (2010). Prevalence and underdiagnosis of chronic obstructive pulmonary disease among patients at risk in primary care. Canadian Medical Association Journal. 182(7). 673–678. 199 indexed citations
5.
Bateman, Eric, Dave Singh, David Smith, et al.. (2010). Efficacy and safety of tiotropium Respimat SMI in COPD in two 1-year randomized studies.. PubMed. 5. 197–208. 67 indexed citations
6.
Hernandez, Paul, Meyer Balter, Jean Bourbeau, & Rick Hodder. (2009). Living with chronic obstructive pulmonary disease: A survey of patients’ knowledge and attitudes. Respiratory Medicine. 103(7). 1004–1012. 71 indexed citations
7.
Hodder, Rick, M. Diane Lougheed, J. Mark FitzGerald, et al.. (2009). Management of acute asthma in adults in the emergency department: assisted ventilation. Canadian Medical Association Journal. 182(3). 265–272. 18 indexed citations
8.
Hodder, Rick, M. Diane Lougheed, Brian H. Rowe, et al.. (2009). Management of acute asthma in adults in the emergency department: nonventilatory management. Canadian Medical Association Journal. 182(2). E55–E67. 25 indexed citations
9.
Hodder, Rick. (2009). Asthma patients prefer Respimat® Soft Mist™ Inhaler to Turbuhaler®. International Journal of COPD. 4. 225–225. 32 indexed citations
10.
Hodder, Rick. (2007). Collaborative self-management education in asthma and COPD*. Canadian Pharmacists Journal / Revue des Pharmaciens du Canada. 140(sp3). s28–s29.e1. 1 indexed citations
11.
Hodder, Rick. (2007). Clinical differences between asthma and chronic obstructive pulmonary disease (COPD)*. Canadian Pharmacists Journal / Revue des Pharmaciens du Canada. 140(sp3). s8–s8. 1 indexed citations
12.
Hodder, Rick. (2007). The Paradox of Adult Asthma Control: “Who’s in Control Anyway?”. Canadian Respiratory Journal. 14(4). 229–234. 5 indexed citations
13.
O’Donnell, Denis E., Shawn D. Aaron, Jean Bourbeau, et al.. (2007). Canadian Thoracic Society Recommendations for Management of Chronic Obstructive Pulmonary Disease – 2007 Update. Canadian Respiratory Journal. 14(suppl b). 5B–32B. 59 indexed citations
14.
Patel, Rakesh, Maureen O. Meade, Lauren E. Griffith, et al.. (2005). Burden of Illness in venous ThromboEmbolism in Critical care: a multicenter observational study. Journal of Critical Care. 20(4). 341–347. 81 indexed citations
15.
Hodder, Rick, et al.. (2005). Low incidence of paradoxical bronchoconstriction in asthma and COPD patients during chronic use of Respimat® soft mist™ inhaler. Respiratory Medicine. 99(9). 1087–1095. 18 indexed citations
17.
O’Donnell, Denis E., Shawn D. Aaron, Jean Bourbeau, et al.. (2003). Canadian Thoracic Society Recommendations for Management of Chronic Obstructive Pulmonary Disease – 2003. Canadian Respiratory Journal. 10(suppl a). 11A–33A. 106 indexed citations
18.
Chapman, Kenneth R., Harvey Kreisman, Robert N. Rivington, et al.. (1990). A comparison of enprofylline and theophylline in the maintenance therapy of chronic reversible obstructive airway disease. Journal of Allergy and Clinical Immunology. 85(2). 514–521. 8 indexed citations
19.
Hodder, Rick, et al.. (1989). The effectiveness of immediate feedback during the Objective Structured Clinical Examination. Medical Education. 23(2). 184–188. 84 indexed citations
20.
Hodder, Rick, et al.. (1984). Pulmonary malakoplakia.. Thorax. 39(1). 70–71. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026